Corporate investors bring a real-world industry lens to the innovations they look at, which often means not going after the ...
Angelini’s corporate venture arm strengthens its biotech portfolio as Swiss Nouscom advances a potential cancer-prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results